Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
396
NCT00831103
A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 30, 2007
Completion: Jun 30, 2009
NCT00575185
Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection
Phase: Phase 1/2
Role: Collaborator
Completion: Feb 28, 2010